ReviewCancer management and research2023

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.

Madison Fraser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.